Evidence map›Paper›PMID 37064542›Full record

ArticleWestern Pacific surveillance and response journal : WPSAR

Epidemiology of tuberculosis in Mongolia: analysis of surveillance data, 2015-2019.

Tsolmon Boldoo, Larissa Otero, Borgil Uranchimeg, Anuzaya Purevdagva, Temuulen Enebish, Oyunchimeg Erdenee, Tauhid Islam, Fukushi Morishita

Abstract read
In one paragraph

Article in Western Pacific surveillance and response journal : WPSAR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tsolmon BoldooNational Tuberculosis Programme, Ministry of Health, Ulaanbaatar, Mongolia.
Larissa OteroInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Borgil UranchimegNational Tuberculosis Programme, Ministry of Health, Ulaanbaatar, Mongolia.
Anuzaya PurevdagvaWorld Health Organization Representative Office for Mongolia, Ulaanbaatar, Mongolia.
Temuulen EnebishNational Tuberculosis Programme, Ministry of Health, Ulaanbaatar, Mongolia.
Oyunchimeg ErdeneeNational Tuberculosis Programme, Ministry of Health, Ulaanbaatar, Mongolia.
Tauhid IslamWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
Fukushi MorishitaWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Mongolia has a high tuberculosis (TB) burden. Data from routine paper-based surveillance were used to describe the epidemiology of TB in Mongolia; the data included testing presumptive TB cases, TB notifications, drug-resistant cases, treatment outcomes and notifications in prisoners. The proportion of the population tested for TB increased between 2015 and 2019. The number and rate per 100 000 population of TB notifications decreased between 2015 and 2018 and then increased in 2019. Most TB notifications in 2019 were in the capital, Ulaanbaatar (59.3%), followed by the central (16.8%), Khangai (10.4%), east (8.5%) and west (5.0%) regions. About half of TB notifications nationally were bacteriologically confirmed (45.4% in 2015, 48.1% in 2019), with the proportion of bacteriologically confirmed TB per province or district varying from 0% to 66%. High TB notification rates were observed in 2019 for males aged 15-54 years (202 per 100 000
population) and females aged 15-34 years (190 per 100 000 population). Treatment success for all forms of TB was 90% in 2019 but was below the 90% target for bacteriologically confirmed cases. Between 2015 and 2019, the number of RR/MDR-TB notifications ranged from 265 to 211. The Mongolian National Tuberculosis Programme needs to continue its efforts in TB control, to further increase the programmatic impact and reduce the TB burden. It is recommended that Mongolia continue to increase TB screening, the use of Xpert testing, contact investigations and preventive treatments, and targeting interventions to the high-burden areas identified in this subnational analysis.

Indexed as

TuberculosisTuberculosis, Multidrug-ResistantContact TracingFemaleHumansMaleMass ScreeningMongolia

Identifiers

PMID37064542
PMCPMC10090033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.